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Recently, amutation in themitochondrial protease Omi/HtrA2, G399S, was found in sporadic Parkinson’s disease (PD) patients, leading
to the designationofOmi/HtrA2 asPD locus 13 (PARK13). G399S reportedly results in reducedOmiprotease activity. In vitro studies have
suggested that Omi/HtrA2 acts downstream of PINK1, mutations in which mediate recessive forms of PD. We, as well as other, have
previously shown that theDrosophila homologs of the familial PD genes, PINK1 (PARK6) and PARKIN (PARK2), function in a common
genetic pathway to regulatemitochondrial integrity and dynamics.WhetherOmi/HtrA2 regulatesmitochondrial integrity andwhether it
acts downstream of PINK1 in vivo remain to be explored. Here, we show thatOmi/HtrA2 null mutants inDrosophila, in contrast to pink1
or parkin null mutants, do not showmitochondrial morphological defects. Extensive genetic interaction studies do not provide support
for models in which Omi/HtrA2 functions in the same genetic pathway as pink1, or carries out partially redundant functions with pink1,
at leastwith respect to regulationofmitochondrial integrity anddynamics. Furthermore,Omi/HtrA2G399S retains significant, if not full,
function of Omi/HtrA2, compared with expression of protease-compromised versions of the protein. In light of recent findings showing
that G399S can be found at comparable frequencies in PDpatients and healthy controls, we do not favor a hypothesis inwhichOmi/HtrA2
plays an essential role in PD pathogenesis, at least with respect to regulation of mitochondrial integrity in the pink1/parkin pathway.
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Introduction
Parkinson’s disease (PD) is characterized by degeneration of ni-
grostriatal dopaminergic neurons in the midbrain (Dauer and
Przedborski, 2003), and genetic forms of the disease have pro-
vided insight into PD pathogenesis (Hardy et al., 2006). Muta-
tions in PINK1 (PARK6), a nuclear gene encoding a mitochon-
drial serine-threonine kinase, and PARKIN (PARK2) cause
recessively inherited forms of PD/parkinsonism (Kitada et al.,
1998; Valente et al., 2004). Drosophila homologs of PINK1 and
PARKIN act in a common genetic pathway (Clark et al., 2006;
Park et al., 2006; Yang et al., 2006) to promote mitochondrial
fission and/or inhibit mitochondrial fusion in multiple tissues,
including dopaminergic neurons (Deng et al., 2008; Poole et al.,
2008; Yang et al., 2008). Consistent with findings in Drosophila,
patients with PINK1 or PARKIN mutations have indistinguish-
able clinical features, and also show mitochondrial defects
(Iba´n˜ez et al., 2006; Dodson and Guo, 2007). Recent studies also
suggest that PINK1 and PARKIN regulate mitochondrial func-
tions in mammals (Exner et al., 2007; Gautier et al., 2008; Piccoli
et al., 2008; Wood-Kaczmar et al., 2008).
Omi/HtrA2 encodes a serine protease localized to mitochon-
drial intermembrane space. Although overexpression of Omi/
HtrA2 leads to apoptosis after its release into the cytosol (for
review, see VandeWalle et al., 2008), mice lackingOmi/HtrA2 or
mice harboring a mutation in Omi/HtrA2 disrupting protease
function (Jones et al., 1993, 2003) show loss of nondopaminergic
neurons in the striatum, but not loss of apoptosis (Rathke-
Hartlieb et al., 2002; Martins et al., 2004). These studies under-
score the importance of studying the in vivo functions of Omi/
HtrA2 using loss-of-function studies.
Recent reports have suggested links between Omi/HtrA2 and
PD (Strauss et al., 2005; Bogaerts et al., 2008). One mutation in
Omi/HtrA2, G399S, was identified in sporadic PD patients and
Received Oct. 24, 2008; revised Nov. 29, 2008; accepted Dec. 1, 2008.
This work was supported by a fellowship from the National Institutes of Health (NIH) National Research Service
Award predoctoral fellowship to M.W.D., as well as grants and funds from NIH (R01, K02, K08), an American
Parkinson Disease Association (APDA) grant, an APDA Center pilot grant, the Glenn Family Foundation, the Alfred P.
Sloan Foundation, and the McKnight Foundation of Neuroscience to M.G. We are very grateful to M. Miura for
antibodies, J. Belote for fly strains, N. Tapon and A.Whitworth for communicating unpublished results, A. Yamagu-
chi for generating one transgenic fly strain, B. A. Hay for insightful comments on this manuscript, F. Laski for use of
hismicrotome, L. Cruz, H. Deng, and J. Olson for technical help, and the Guo laboratorymembers for discussions. J.Y.
and J.H.C. performed experiments, M.W.D. performed most of the transmission electron microscopy studies, I.E.C.,
P.K., andR.B.C. contributed reagents, andM.G. performedexperiments, supervised the project, andwrote the paper
with helpful comments fromM.W.D. and J.Y.
Correspondence should be addressed to Dr. Ming Guo, Departments of Neurology and Molecular and Medical
Pharmacology, University of California, Los Angeles, 695 Charles Young Drive South, Los Angeles, CA 90095. E-mail:
mingfly@ucla.edu.
J. H. Cao’s present address: Department of Chemistry and Biochemistry, University of California, Los Angeles, Los
Angeles, CA 90095.
R. B. Chowdhury’s present address: Wales Cancer Trial Units, Neuadd Meirionnydd University Hospital of Wales,
Cardiff CF14 4YS, UK.
I. E. Clark’s present address: Department of Molecular, Cellular, and Developmental Biology, University of Cali-
fornia, Los Angeles, Los Angeles, CA 90095.
DOI:10.1523/JNEUROSCI.5141-08.2008
Copyright © 2008 Society for Neuroscience 0270-6474/08/2814500-11$15.00/0
14500 • The Journal of Neuroscience, December 31, 2008 • 28(53):14500–14510
reportedly impairs activation of protease activity. In addition,
Omi/HtrA2 can physically bind to PINK1 in vitro, and Omi/
HtrA2 can be phosphorylated by a serine-threonine kinase, p38,
with this phosphorylation being dependent on PINK1. Further-
more, substitution of a putative PINK1-dependent phosphoryla-
tion site with a nonphosphorylatable moiety (S400A) markedly
reduced protease activity (Plun-Favreau et al., 2007). Thus, it has
been suggested thatOmi/HtrA2 functions downstreamofPINK1,
with PINK1 positively regulating Omi/HtrA2 (Plun-Favreau et
al., 2007). Based on these intriguing links between Omi/HtrA2
and PD, Omi/HtrA2 was recently designated as Parkinson
disease-13 locus (PARK13).
However, two recent human genetic studies report no associ-
ation of Omi/HtrA2 with PD (Ross et al., 2008; Simo´n-Sa´nchez
and Singleton, 2008), with the G399S allele detected in both PD
patients and healthy controls at a similar frequency. Because of
these conflicting results, it is unclear whetherOmi/HtrA2 acts as a
true PD gene and whether it performs a major function down-
stream of PINK1. Resolution of these questions is crucial for
understanding PD pathogenesis. Studies on the endogenous
function of Omi/HtrA2 as it relates to PINK1 function are re-
quired to address these questions. Here, we report studies on
loss-of-function and disease-associated mutants of Drosophila
omi, and the results of extensive genetic interaction studies be-
tween pink1 and omi.
Materials andMethods
Molecular biology. To generate UAS-omi, GMR-omi, and TMR-omi, the
omi cDNA (EST clone from Drosophila Genome Research Center,
AT14262) was subcloned into each vector (Brand and Perrimon, 1993;
Hay et al., 1994; Huh et al., 2004). To generate Drosophila Omi mutants
analogous to human Omi/HtrA2 mutations, S276C, S306A, G399S, and
S400A, site-specific mutagenesis of S236C, S266A, G363S, and S364A of
Omi was carried out, and the altered cDNAs were subcloned into pUASt
and pTMR vectors, respectively. A fly mutation corresponding to the
human PINK1G309D mutation, Pink1G426D, was generated by site-
specific mutagenesis (made by I.E.C. and Atsushi Yamaguchi, Novato,
CA). To silence omi, the omi transcript corresponding to the coding
region was targeted using a microRNA-based technology (Chen et al.,
2007) (Ganguly et al., 2008), and PCR products of these microRNA
precursors were cloned into pUASt. To generate CaSpeR-pink1G426D,
site-specific mutagenesis in the backbone of CaSpeR-pink1 was per-
formed and the product subcloned into pCaSpeR4 vector. To generate
CaSpeR-omi, a 2.5 kb PCR product, generated using the following prim-
ers, was subcloned into pCaSpeR4 vector (a gift from Nic Tapon, Lon-
don, UK): 5 primer: CAACTCGAGGAAGTACATTGGGCGGGTC; 3
primer: GGGACTAGTGGGTTTGTCAGCGATTTC. All cloned PCR
products were confirmed by DNA sequencing.
Drosophila genetics and strains. EMS mutations were recovered using
the Drosophila Tilling Service (Fred Hutchinson Cancer Research Cen-
ter). These alleleswere generated in a previous screen (Koundakjian et al.,
2004). omiNSO is a nonsense allele resulting from a base substitution of C
to T, leading to generation of a stop codon at Q196, and omiV110E is a
missense allele resulting from substitution of T to A. We independently
confirmed these alleles by sequencing. Pros6T-GFP flies (Zhong and
Belote, 2007) were obtained from J. M. Belote (Syracuse, NY), and UAS-
mitoGFP and Df(3R)ED5644 flies were obtained from the Bloomington
Drosophila Stock Center. pink15, TMR-pink1, UAS-pink1, and CaSpeR-
pink1–9myc (Clark et al., 2006), UAS-parkin (Greene et al., 2003), and
Mef2-Gal4 (Deng et al., 2008) flies have been previously described. For
experiments involving transgenic flies, multiple independent fly lines
were generated (Rainbow Transgenic Flies) and tested for each trans-
gene. Drosophila strains were maintained in an 18°C, 25°C, or 29°C hu-
midified incubator, or at room temperature.
Male and female fertility tests. Recently eclosed individual male flies
were placed with four virgin females in vials. Single 0- to 3-d-old females
were placed in a vial supplemented with dry yeast along with five sibling
males and maintained at 25°C. Males or females were scored as sterile if
they failed to produce progeny by day 6.
Phase-contrast, immunofluorescence, and confocal microscopy. For light
microscopic analysis of the male germline, testes were dissected from
recently eclosed males, squashed in PBS buffer, and imaged using an
Olympus BX51 microscope equipped with phase-contrast optics. For
analysis of muscle, nota of adult flies were dissected and fixed in 4%
paraformaldehyde, and indirect muscle fibers were isolated and imaged
by a Zeiss LSM5 confocal microscope. For analysis of dopaminergic neu-
rons, anti-tyrosine hydroxylase (TH) (Immunostar) antibodies were
used and imaged by a Zeiss LSM5 confocal microscope, and only clearly
stained anti-TH-positive cells were counted.Wild-type, pink1mutant, or
omimutant brains were counted blindly. The Immunofluorescent stain-
ing was performed as previously described (Guo et al., 1996). Phalloidin
was used 1:1000 for testes staining (Invitrogen). Anti-Omi antibodies
were a kind gift from M. Miura (Tokyo, Japan) and were used 1:300 for
immunocytochemistry.
Transmission electron microscopy. Testes and muscle were dissected,
fixed in paraformaldehyde/glutaraldehyde, postfixed in osmium tetrox-
ide, dehydrated, and embedded in Epon. Toluidine bluewas used to stain
1.5-m-thick tissue sections. Thin sections (80 nm thick) were stained
with uranyl acetate and lead citrate, and examined using a JEOL 100C
transmission electron microscope (University of California, Los Angeles
Brain Research Institute Electron Microscopy Facility). At least three
testes or thoraces of each genotype were examined by transmission elec-
tron microscopy (EM).
Scanning electron microscopy. Freshly killed flies were mounted on
their sides, placed on a platform under vacuum, and imaged at 180
magnification and 100 psi using a Hitachi 2460N scanning electron mi-
croscope. Analysis of eye phenotypes was performed as previously de-
scribed (Guo et al., 2003; Gross et al., 2008).
Stress and longevity assays. Zero- to three-day-old males were anesthe-
tized on ice, aged for 48 h, starved for 6 h, and subjected to 5% sucrose
plus each agent. Four vials of 30 flies were assayed simultaneously for
each genotype. For longevity measurements, 120 males of each genotype
were divided into six vials. Flies were maintained at 25°C and transferred
to fresh food every 2 d.
Lysate preparation andWestern blotting.Heads or testes from age- and
sex-matched adults were disrupted in lysis buffer containing complete
protease inhibitor mixture (Roche) using a sonicator-3000 fromMISO-
NIX. Samples were boiled and centrifuged, and total protein was ana-
lyzed by Western blotting. Antibodies used were anti-Myc (Millipore)
and anti-Omi (Igaki et al., 2007).
Northern blotting. Standard protocols were used using a full-length
pink1 probe as previously described (Clark et al., 2006).
Results
Overexpression-based genetic interactions of pink1 and omi
in the eye
Omi/HtrA2 encodes a protein with a mitochondrial targeting se-
quence and a transmembrane domain, followed by a serine pro-
tease domain and a C-terminal PSD-95/DlgA/Zo-1 (PDZ) do-
main (Vande Walle et al., 2008). Drosophila melanogaster
contains a single homolog of Omi/HtrA2 (CG8464, hereafter
called omi), with 50% amino acid sequence identity, 68% simi-
larity, and a domain structure similar to that of human Omi/
HtrA2. To test the hypothesis that omi and pink1 function in the
same pathway, we asked whether genetic interactions between
these two genes could be observed in the Drosophila eye. The fly
eye is dispensable for viability and fertility, and has been widely
used as a system to study human neurodegenerative diseases [for
review, see Bonini and Fortini (2003) andMarsh and Thompson
(2006)]. We generated transgenic flies to carry out tissue-specific
overexpression using the UAS-Gal4 system (Brand and Perri-
mon, 1993).When omiwas overexpressed at high levels in the eye
(25 or 29°C), small and rough eyes were observed (Fig. 1K com-
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pared with A), similar to a previously re-
port (Igaki et al., 2007). These small eyes
likely result from the ability of Omi to ac-
tivate cell death when overexpressed
(Challa et al., 2007; Igaki et al., 2007; Khan
et al., 2008). The eye phenotypes resulting
from omi overexpression were very sensi-
tive to the level of omi expression. Flies
expressing lower levels of omi (18°C) ex-
hibited wild-type-appearing eyes, provid-
ing a sensitized genetic background for in-
teraction studies (Fig. 1B). Eye-specific
pink1 overexpression resulted in mild
rough eyes (Fig. 1C) (Poole et al., 2008).
However, flies overexpressing both pink1
and omi at 18°C exhibited smaller and
rougher eyes than those associated with
pink1 overexpression alone (Fig. 1F). This
suggests that there is an overexpression-
based interaction between pink1 and omi,
which is consistent with a recent report
(Whitworth et al., 2008) and has been in-
terpreted, in conjunction with other ob-
servations, as indicating that omi acts
downstream of pink1 in a common genetic
pathway (Whitworth et al., 2008).
One possible explanation for the inter-
action observed when pink1 and omi are
coexpressed is that overexpression of two
mitochondrially targeted proteins causes
competition for limited amounts of mito-
chondrial import machinery. In such a
model, increased import of Pink1 could
lead to excess Omi in the cytosol, resulting
in a rough eye. Overexpression of a mito-
chondrial matrix-targeted green fluores-
cent protein (mitoGFP) with either pink1
or omi, however, did not lead to any en-
hancement of omi or pink1 overexpression
phenotypes, suggesting that mitochon-
drial import is not limited (supplemental
Fig. S1, available at www.jneurosci.org as
supplemental material). The omi/pink1
co-overexpression interaction was dependent on the protease ac-
tivity of Omi, because flies overexpressing a protease-dead ver-
sion of Omi, Omi-S266A (Fig. 1D and see below), failed to show
enhanced eye phenotypes when in conjunction with pink1 over-
expression (Fig. 1G).
Further exploring the hypothesis that omi acts downstream of
pink1, we found that pink1 overexpression-induced eye pheno-
types could not be suppressed by loss of omi function (Fig. 1 I, J).
Similarly, the eye phenotype resulting from omi overexpression
could not be modified by lack of pink1 (Fig. 1K,L). Thus, these
results do not provide support for omi functioning downstream
of pink1. We next explored the relationship between these inter-
actions observed in the eye and the well characterized functions
of pink in regulating mitochondrial morphology. We generated
transgenic flies expressing Pink1G426D, a Drosophila mutation
analogous to the PINK1 PD-associatedmutation G309D. G309D
alters a residue in the kinase domain (Valente et al., 2004) and has
a significant reduction of PINK1 kinase activity, as assayed by in
vitro autophosphorylation (Beilina et al., 2005). pink1 null mu-
tant flies carrying G426D showed a largely abolished ability to
rescue male sterility (2% fertile, n 60), muscle degeneration,
and mitochondrial morphological defects of pink1 null mutants
(Fig. 2), indicating that this mutant protein is strongly compro-
mised with respect to normal pink1 function. Surprisingly, how-
ever, expression of Pink1G426D still led to a small and rough eye
phenotype when combined with omi overexpression (Fig. 1H).
These results suggest that pink1 functions required to mediate
omi overexpression-based interactions in the eye are distinct
from pink1 functions required to provide normal mitochondrial
function. Together, although omi and pink1 displayed genetic
interactions in overexpression-based assays, these results do not
provide evidence to support models in which omi plays a major
role in transducing pink1-dependent signals to regulate mito-
chondrial function.
omi null mutants are male sterile, but show phenotypes
distinct from those seen in pink1 or parkin null mutants
To further explore the roles of omi as it relates to pink1, we per-
formed loss-of-function studies of omimutants. The endogenous
functions of omi in Drosophila have not been fully studied be-
Figure 1. Overexpression-based genetic interactions between pink and omi. Scanning EM and lightmicrographs ofDrosophila
eyes are shown. At 18°C, omi overexpression (B) results inwild-type-appearing eyes,whereas overexpression of pink1 (C) leads to
mild rough eyes. Overexpression of both omi and pink1 results in a small and rough eye (F ). This pink1-omi overexpression
interaction is abolished with expression of a protease-inactive version of Omi, S266A (G). Expression of OmiS266A by itself does
not result in any eye phenotypes (D). Expression of amutation analogous to the Pink1 diseasemutant, G426D, has no phenotype
(E); however, it still shows an interaction with omi overexpression (H ). The phenotype of pink1 overexpression cannot be sup-
pressed by loss of omi function induced by RNAi-omi, even when raised at 29°C (I, J ). Silencing of omi function by RNAi-omi is
strong because it completely suppresses the omi overexpression-induced eye phenotype (supplemental Fig. S2, available at
www.jneurosci.org as supplemental material). Similarly, the eye phenotype resulting from omi overexpression cannot be modi-
fied by lack of pink1 (K, L). A–H are from flies raised at 18°C, whereas I–L are from flies raised at 29°C. Genotypes: Control: w;
GMR-Gal4/. Omi: w; GMR-Gal4, UAS-omi/. Pink1: w; GMR-Gal4, UAS-pink1/. Pink1G426D: w; GMR-Gal4/UAS-
Pink1G426D. OmiPink1: w; UAS-omi/; GMR-Gal4, UAS-pink1/. OmiPink1G426D: w; GMR-Gal4, UAS-omi/UAS-
Pink1G426D. Pink1OmiS266A: w; UAS-OmiS266A/; GMR-Gal4, UAS-pink1/. Pink1omi loss of function (lof): w; GMR-
Gal4, UAS-pink1/UAS-RNAi-omi. Omipink1 lof:w pink15; GMR-Gal4, UAS-omi/.
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cause of the absence of loss-of-function mutants. This analysis is
more relevant to the role of omi as it relates to PD, because mu-
tations in omi observed in PD patients are postulated to be loss-
of-function or dominant-negative mutations, not resulting in
increased activity. To obtain loss-of-function mutations in omi,
we used TILLING (Till et al., 2003), a method for detecting ethyl
methanesulfonate (EMS)-induced point mutations in a gene of
interest after chemical mutagenesis. We obtained one nonsense
mutation in omi, omiNSO, and onemissensemutation,V110E (see
below). The truncated protein encoded by omiNSO is predicted to
lack the active site of the protease domain and the PDZ domain
(Fig. 3A), and thus represents a null allele. Flies homozygous for
omiNSO were semilethal. However, flies carrying omiNSO in trans
to a deficiency in the region, Df(3R)ED5644, were fully viable,
suggesting that the lethality associated with omiNSO is caused by a
backgroundmutation. Flies with ubiquitous expression of RNAi-
omi using a tubulin-Gal4 driver were also viable. The silencing
effect of RNAi-omi was confirmed by its ability to completely
suppress omi overexpression-induced eye phenotypes (supple-
mental Fig. S2, available at www.jneurosci.org as supplemental
material). As expected, Western blotting using an anti-Omi an-
tibody revealed no detectable Omi-positive bands in omiNSO/
Df(3R)ED5644 flies (supplemental Fig. S3, available at www.
jneurosci.org as supplemental material).
omiNSO/Df(3R)ED5644 flies, hereafter called omimutants, did
not show any gross external defects. omi mutant females were
fertile (96%, n 50), but omimutant males were sterile (100%,
n  110). In these males, seminal vesicles, which store mature
sperm, were empty (Fig. 3D,D), and no motile sperm were ob-
served, suggesting defects in either production or transport to the
seminal vesicles. To ensure that these phenotypes were attribut-
able to lack of omi, we generated multiple transgenic fly lines
expressing omi specifically in the male germline (TMR-omi).
Overexpression of omiwas confirmed using anti-Omi antibodies
(supplemental Fig. S3, available at www.jneurosci.org as supple-
mentalmaterial).Many of these lines weremale sterile. However,
three of 10 lines were fertile. Those fertile lines show weaker
overexpression of omi than the sterile lines (supplemental Fig. S3,
available at www.jneurosci.org as supplemental material). This
suggests that the sterility is caused by a high level of overexpres-
sion, likely resulting in promiscuous activity of theOmi protease.
Introduction of any of the fertile omi overexpression lines into
the omi mutant background resulted in the presence of motile
sperm in the seminal vesicles (Fig. 3E,E) and restoration of fer-
tility (95%, n 100). A single copy of a genomic rescue transgene
containing omi, but not surrounding genes, also fully rescued the
male sterility of omi mutants (100%, n  50). Together, these
results demonstrate that omi is essential for spermatogenesis.
We also analyzed the second omi EMS allele. V110 corre-
sponds to V154 in human Omi/HtrA2, which is located in a
highly conserved region (Fig. 3A,B) predicted by structural stud-
ies to mediate homo-trimerization of Omi/HtrA2, which is re-
quired to activate its protease activity (Li et al., 2002). omiV110E/
Df(3R)ED5644 and omiV110E/omiNSO mutant flies were also male
sterile (0%, n 45; 0%, n 65), displayed empty seminal vesi-
cles, and had no motile sperm, indicating that omiV110 is likely a
null or strong hypomorphic allele. These results provide in vivo
support for an important role for the trimerizationmotif forOmi
function, and suggest that the protease activity of Omi is crucially
important for its role in regulating spermatogenesis.
Because pink1 mutants also show male sterility, we asked
whether omi mutant testes show defects in mitochondrial mor-
phology, a prominent feature of pink1mutants (Clark et al., 2006;
Deng et al., 2008). During Drosophila spermatogenesis, mito-
chondria undergo significant morphological changes (Fuller,
1993). Stem cell differentiation is followed bymitosis andmeiosis
with incomplete cytokinesis, creating syncytial cysts of 64 sper-
matids. Early spermatids undergo mitochondrial aggregation
and fusion, creating two giantmitochondria that form a spherical
structure known as the nebenkern (Fuller, 1993). Under phase-
contrast microscopy, such “onion stage” spermatids can be iden-
tified as having two adjacent spherical structures: the nucleus and
the nebenkern (Fig. 3 I, J). During subsequent spermatid elonga-
tion, the nebenkern begins to unfurl, creating two mitochondria
at this “leaf-blade” stage (Fig. 3 I,M). After elongation, sperma-
tids undergo a process known as individualization, in which the
Figure 2. mRNA expression and phenotypic analysis of Pink1G426D, a mutation analogous
to PD-associatedmutation PINK1G309D. A, Northern blot of whole flies using full-length pink1
as a probe. Compared with wild type, pink1 null mutant ( pink15) flies do not show full-length
mRNA. Transgenic flies expressing pink1G426Dmutants show comparable or higher expression
of pink1 than is seen in flies expressing wild-type pink1. The arrow points to pink1 expression,
and rp49 (*) serves as an RNA loading control. B–J, Schematic (B) and phase-contrast micro-
graphs of spermatid mitochondria during the “onion stage” (C–F ) and “the leaf blade stage”
(G–J ). Compared with wild type, pink1 mutants show vacuolation (red arrowheads) in the
nebenkern during the onion stage (D), and one instead of the two mitochondrial derivatives
(yellow arrows) seen in wild type at the leaf blade stage (H ). A genomic rescue transgene
carrying wild-type pink1 (CaSpeR-pink1) completely rescues the male sterility resulting from
lack of pink1 (100% fertile, n 120) (Clark et al., 2006), and spermatid phenotypes in both the
onion stage and the leaf-blade stage (F, J ). In contrast, pink1G426D (CaSpeR-pink1G426D) fails
to rescue the sterility of pink1males (2% fertile, n 60) or the spermatid phenotypes (E, I ).
Redarrowheadspoint to vacuolationof thenebenkern, andyellowarrowsmarkeachmitochon-
drial derivative.K–N, Mitochondria of indirect flightmuscle are labeled bymitoGFP. Compared
with control (K ), pink1 mutants display overall reduced levels of mitoGFP signal and large
clumps of intense GFP signal (L), which can be completely rescued by overexpression of
Pink1WT (N ), but not Pink1G426D (M ).
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cytoplasmic bridges that link the 64 spermatids within a cyst are
broken and excess cytoplasm is extruded (Fuller, 1993). This in-
dividualization process requires synchronized movement of an
actin-based structure known as the investment cone. After indi-
vidualization, each spermatid tail consists largely of the axoneme,
a microtubule-based structure required for motility, and mito-
chondrial derivatives (Fig. 3P,Q).
As expected for a protein with a mitochondrial targeting se-
quence, Omi localizes to nebenkerns (see Fig. 6A–C). In onion-
stage spermatids, the nebenkerns of pink1mutants show signifi-
cant vacuolation (Fig. 3L), and during the subsequent leaf blade
stage pink1 and parkin mutants contain only one mitochondrial
derivative (Fig. 3O) rather than the two seen in wild type (Fig.
3M) (Clark et al., 2006; Riparbelli and Callaini, 2007; Deng et al.,
2008). Surprisingly, mitochondria in omimutants were indistin-
guishable from those in wild type. During the onion stage, the
border of the nebenkern was smooth and no vacuolation was
observed (Fig. 3K). At the leaf blade stage, omi mutant sperma-
tids contained two mitochondrial derivatives instead of one ob-
served in pink1 or parkin mutants (Fig. 3N). pink1 and parkin
mutants also show dramatic defects in mitochondrial morphol-
ogy during postindividualization stages, as visualized with trans-
mission EM (Fig. 3S) (Greene et al., 2003; Clark et al., 2006;
Riparbelli and Callaini, 2007; Deng et al., 2008). In contrast, mi-
tochondria appeared normal in stage-matched omi mutants, al-
though individual spermatids were somewhat disorganized
within the cyst (Fig. 3R). In addition, investment cones in omi
mutants were scattered (Fig. 3G compared with F), suggesting
that movement of these structures is asynchronous. Such a phe-
notype is associated with individualization defects (Huh et al.,
2004). Although the individualization defects were suppressed by
testes-specific omi overexpression (Fig. 3H), we cannot rule out
the possibility that defects in other postindividualization steps of
spermatogenesis also contribute to sterility associated with omi
mutants. This possibility seems particularly likely because the
individualization defects observed in omi mutants appear rela-
tively mild. In summary, omi mutant phenotypes in testes are
distinct from those of pink1 or parkin mutants, in which defects
in mitochondrial morphology are observed.
In contrast to pink1mutants, omimutants do not show
dopaminergic neuronal loss, muscle degeneration, or defects
in mitochondrial integrity
Next, we asked whether omimutants show phenotypes similar to
those of pink1mutants in other tissues and contexts. omimutants
were sensitive to treatments withmultiple stress-inducing agents,
including paraquat, a free radical inducer; rotenone, which im-
pairs complex I activity in the mitochondrial respiratory chain
(Przedborski and Ischiropoulos, 2005); protein folding inhibi-
tors; and high concentrations of salt (supplemental Fig. S4, avail-
able at www.jneurosci.org as supplemental material). Thus,
rather than being specifically sensitive to oxidative stress, omi
mutant flies are generally stress sensitive. These results may sug-
gest a general sickness of omi mutants, particularly because omi
mutants had a shortened life span (supplemental Fig. S5, avail-
able at www.jneurosci.org as supplemental material).
An age-dependent decrease in the number of dopaminergic
neurons has been reported in pink1 or parkinmutants (Meulener
Figure 3. omi null mutants show defects in spermatogenesis, but have normal mitochon-
drial morphology in testes.A, Schematic depicting domains of Omi. MTS,Mitochondrial target-
ing sequence. TM, Transmembrane domain. IBM, IAP-binding motif. The exact locations of
omiNSO and omiV110E are depicted as blue and red asterisks, respectively.B, Sequence alignment
of Omi/HtrA2 in various species in a highly conserved region, in which the conserved valine,
mutated in omiV110E, is marked in red. C–E, C–E, Phase-contrast micrographs of testes. In
contrast to a control fly (C, C), inwhich the seminal vesicle (arrow) is full of sperm (phase dark),
omi mutants (D, D) show an empty seminal vesicle (bracket with an asterisk), which can be
rescuedby omioverexpression (E,E) (arrowpointing to the seminal vesicle).C–E are higher-
magnification views of the seminal vesicle from C–E. F–H, Phalloidin staining of investment
cones within one syncytial cyst. In contrast to controls, in which investment cones are well
aligned, indicating synchronizedmovement (F ),omimutants showscattered investment cones
in some of the cysts, indicative of amild defect in individualization (G), which can be rescued by
omi overexpression (H ). I–O, Schematics and phase-contrast micrographs of spermatid mito-
chondria during the “onion stage” (I–L) and “the leaf blade stage” (I, M–O). Compared with
wild type (J, M ), omi mutants do not show any defects in either stage (K, N ), whereas pink1
mutants show vacuolation (red arrowheads) in the nebenkern during the onion stage (L), and
one instead of the two mitochondrial derivatives (yellow arrows) seen in wild type at the leaf
blade stage (O). P–S, Schematic and transmission EM images of a portion of a postindividual-
ization cyst. Each spermatid contains anaxoneme (orangearrows) andmitochondrial derivative
(red arrowheads) within an individual plasma membrane. The omi mutant cyst (R) shows
disorganization of spermatids and occasional individualization defects (data not shown). How-
ever, comparedwithpink1mutants,which showsevere impairment in the size andmorphology
of mitochondria (S), omimutant cysts show normal-appearing mitochondria (R). Genotypes:
4
wild type: w/Y; control: w/Y; omiNSO/; omimutant: w/Y; omiNSO/Df(3R)ED5644; omimutant
 rescue:w/Y; TMR-omi/; omiNSO/Df(3R)ED5644. Scale bars: C–E, 500m; Q–S, 500 nm.
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et al., 2005; Park et al., 2006; Yang et al., 2006) (Fig. 4A,B,D,E). In
contrast, omimutants did not show any dopaminergic neuronal
loss in the brains of flies aged for 40 d (Fig. 4C,F). pink1 or parkin
mutants also show striking indirect flight muscle degeneration
and severely disrupted mitochondrial morphology with broken
cristae, which are prominent in 1- to 2-d-old flies (Fig. 4 I, J com-
pared with G,H) (Greene et al., 2003; Pesah et al., 2004; Clark et
al., 2006; Park et al., 2006; Yang et al., 2006). In contrast, although
Omi is expressed in muscle and localized to mitochondria (data
not shown), omi mutants did not exhibit any muscle degenera-
tion, even when they were aged for 30 d (Fig. 4K). EM analysis of
omimutant muscle also failed to show any defects in mitochon-
drial integrity (Fig. 4L). Together, our data demonstrate that omi
mutants, in contrast to pink1mutants, do not display mitochon-
drial morphological defects in multiple tissues, including sper-
matids and muscle. omimutants also fail to show dopaminergic
neuronal loss seen in pink1mutants.
Loss-of-function studies fail to detect any genetic interactions
between pink1 and omi
To further explore the hypothesis that omi and pink1 work to-
gether to regulate mitochondrial integrity, we searched for ge-
netic interactions based on loss of function of these genes. Ge-
netic interactions between pink1 and parkin provide an
important reference for testing whether omi and pink1 act in a
common pathway (Clark et al., 2006; Park et al., 2006). We, as
well as others, have previously shown that Drosophila pink1 and
parkin act in a common genetic pathway, with pink1 functioning
upstreamof parkin (Clark et al., 2006; Park et al., 2006; Yang et al.,
2006). This conclusion is based on several observations. Loss-of-
functionmutations in pink1 and parkin result in highly similar, if
not identical, defects in mitochondrial integrity (Clark et al.,
2006; Park et al., 2006; Yang et al., 2006; Deng et al., 2008; Poole
et al., 2008). Although overexpression of parkin rescues pink1
null mutant phenotypes, overexpression of pink1 fails to rescue
parkin null mutant phenotypes (Clark et al., 2006; Park et al.,
2006). In addition, double mutants removing both pink1 and
parkin show phenotypes identical to those of single mutants
alone (Clark et al., 2006; Park et al., 2006).
In contrast to pink1 (Fig. 5C,H) or parkin overexpression
(Clark et al., 2006), testes-specific omi overexpression did not
rescue themale sterility or the mitochondrial phenotype of pink1
mutants (0% fertile, n  65) (Fig. 5D, I). Expression of mutant
versions of Omi analogous to S306A, S276C, G399S, or S400A
(see below) also did not rescue male sterility of pink1 mutants
(0% fertile, n 30). Similarly, omi overexpression, which leads to
massive loss of muscle integrity, also failed to rescue the muscle
degeneration phenotypes seen in pink1mutants. In addition, ex-
pression of a protease dead version of Omi, S266A, which does
not result in loss of muscle integrity, also failed to rescue muscle
phenotypes seen in pink1mutants (data not shown). Consistent
with the hypothesis that pink1 and omi function independently,
neither the expression levels nor the mitochondrial localization
of Omi was altered in pink1mutants (Fig. 6D–F).
To investigate whether pink1 functions downstream of omi,
we performed reverse rescue experiments. However, pink1 over-
expression failed to rescuemale sterility seen in omimutants (0%
fertile, n 70). In addition, neither the protein levels nor cleav-
age patterns of Pink1 were altered in omimutants (Fig. 6). Thus,
we failed to find any positive evidence that omi functions either
upstream or downstream of pink1 in a common pathway.
To test the hypothesis that omi might function in a parallel
pathway with pink1 in a partially redundant manner, we gener-
ated double mutants that remove both pink1 and omi. These
double mutant flies were viable and showed survival rates com-
parable to those of pink1mutants alone. These animals weremale
sterile and exhibited mitochondrial morphological defects in
spermatids and muscle that were indistinguishable from those of
pink1mutants alone, indicating that loss of omi function does not
enhance pink1 mutant phenotypes (Fig. 5E, J,N; compare with
B,G,L). Together, our loss-of-function in vivo studies do not pro-
vide support for the hypothesis that omi functions either up-
Figure 4. omi null mutants do not show dopaminergic neuronal loss, muscle degeneration, or
mitochondrial morphological defects. A–C, Anti-tyrosine hydroxylase immunostaining of whole-
mount brains from40-d-oldwild-type (A), pink1mutant (B), and omimutant (C) flies. Seventeen to
twenty-seven individual flies (both hemispheres) were counted for each genotype. D, Schematic
depicting locations of the major dopaminergic neuron clusters in the adult brain as designated by
abbreviations(Na¨sselandElekes,1992).Themajordopaminergicneuronclustersare locatednear the
posterior surface of the brain, with the exception of the protocerebral anterior lateral (PAL), which is
locatednear the anterior surface (labeled ingray). PPL, Protocerebral posterior lateral; PPM,protoce-
rebral posteriormedial; VUM, ventral unpairedmedial. E, F, Quantification of dopaminergic neurons
ineachcluster inpink1mutantfliesandwild-typeflies(E),andomimutantfliesandwild-typeflies(F )
agedfor40dat25°C.Errorbars representSDs,andStudent’s t test isused for statisticalanalysis.*p
0.05; **p0.01.G–L, Toluidineblue stainingof indirect flightmuscle fibers (G, I,K ) andEMstudies
of thesemuscles(H,J,L).Thebordersofmitochondriaaremarkedwithwhitedashedlines. Incontrast
topink1mutants (I, J ),omimutantsdonot showmuscledegenerationormitochondrialmorpholog-
ical defects (K, L), even when aged for 30 d. Genotypes: wild type:w/Y. omimutant:w/Y; omiNSO/
Df(3R)ED5644. pink1mutant:wpink15/Y. Scale bars:H, J, L, 1m.
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stream or downstream of pink1, or in par-
allel with pink1, at least with respect to the
regulation of mitochondrial integrity.
PD-associated mutations in Omi, and a
mutation abolishing a putative Pink1-
dependent phosphorylation site, show
distinct phenotypes frommutations
impairing Omi protease function
Because we failed to detect any loss-of-
function-based genetic interactions be-
tween pink1 and omi, we decided to exam-
ine the function of the PD disease-related
omi mutations. The PD-associated poly-
morphism in Omi/HtrA2, A141S (de-
tected in1% of the normal population),
and the mutation, G399S, have been re-
ported to function as dominant-negative
mutations, leading to a reduction of pro-
tease function of Omi/HtrA2 (Strauss et
al., 2005). G399, which is located in the
PDZ domain, is conserved in Drosophila,
whereas A141, which is located in the IAP-
binding domain of Omi/HtrA2, is not. In-
terestingly, S400, a residue next to G399,
has been identified as a PINK1-dependent
putative phosphorylation site for p38
(Plun-Favreau et al., 2007). This phos-
phorylation is reported to be important
for Omi/HtrA2 activity, because S400A, a
phosphorylation-incompetent mutation,
markedly reduces protease activity (Plun-
Favreau et al., 2007). To investigate
whether these mutations affect Omi/
HtrA2 function in vivo, we generated
transgenic flies expressing Omi G363S or S364A, which are anal-
ogous to G399S or S400A in human Omi/HtrA2.
Both G399S and S400A reportedly compromise Omi protease
activity in vitro (Strauss et al., 2005; Plun-Favreau et al., 2007). If
this were true in vivo, G399S or S400A mutant forms of Omi
would be expected to show similar phenotypes to protease-
compromised Omimutants. To test this hypothesis, we also gen-
erated two protease-impaired versions ofDrosophilaOmi, S266A
and S236C. S266A is analogous to S306A in human Omi/HtrA2,
which alters the active site serine in the protease domain and
abolishes protease activity (Li et al., 2002), and S236C is analo-
gous to the S276C mutation present in the mnd2 mice, which
significantly reduces the protease function of Omi/HtrA2 (Jones
et al., 2003) (Table 1). Thesemutants were expressed and assayed
in multiple somatic tissues using the UAS-GAL4 system (Brand
and Perrimon, 1993), and in the male germline using the TMR
promoter (Huh et al., 2004; Clark et al., 2006). The actions of
G363S and S364A were compared with that of wild-type Omi
(Omi WT), as well as the protease-deficient S266A and S236C
mutant forms.
In contrast to overexpression of Omi WT, which resulted in
male sterility inmost transgenic lines, all transgenic lines express-
ing S266A or S236C were male fertile (n  13 transgenic lines
tested for eachmutant). Expression of S266A also failed to rescue
the male sterility (0% fertile, n 60) and empty seminal vesicle
phenotypes resulting from lack of omi (Fig. 7B, Table 1). These
data suggest that protease-compromised mutations result in loss
of Omi function. Further supporting this hypothesis, eye-specific
overexpression of S266A or S236C, in contrast to overexpression
of Omi WT, resulted in wild-type-appearing eyes (Fig. 7E–G,
Table 1). Similarly, muscle-specific overexpression of S266A or
S236C, in contrast to Omi WT, did not affect muscle integrity
(Table 1, data not shown). Expression of S266A and S236C were
confirmed using an anti-Omi antibody (Fig. 7D). These results,
together with those described earlier with themissensemutation,
omiV110E, in the region responsible for activation of protease ac-
tivity, suggest that Omi protease activity is important for its func-
tion in vivo.
In contrast, testes-specific expression of either OmiG363S or
S364A resulted in significant male sterility, with only 3–4 lines of
the 10–13 lines tested per construct giving fertilemales, similar to
what is seen with overexpression of Omi WT. These fertile lines
likely represent those with lower expression levels. Using these
fertile lines, we found that expression of G363S rescued the ste-
rility and individualization phenotypes resulting from omi loss of
function, as did those expressing Omi WT (Fig. 7C, Table 1).
These results suggest that mutations analogous to G399S and
S400A retain a significant amount of Omi activity. Further sup-
porting this hypothesis, eye-specific overexpression of G363S or
S364A resulted in small and rough eyes similar to those seen after
overexpression of Omi WT (Fig. 7H–J, Table 1). Similarly,
muscle-specific overexpression of G363S or S364A, or Omi WT,
resulted in a massive loss of muscle integrity (Table 1, data not
shown). Together, these observations (summarized in Table 1)
suggest thatOmimutant proteins analogous toG399S and S400A
Figure 5. Lack of genetic interactions between pink1 and omi in loss-of-function studies of mitochondrial morphology. A–J,
Phase-contrast micrographs of spermatid mitochondria during the “onion stage” (A–E) and “the leaf blade stage” (F–J ). pink1
null mutants show vacuolation of nebenkerns (B) and one singlemitochondrial derivative (G). This phenotype can be completely
suppressedbypink1overexpression (overexpr.) (C,H ), but not byomioverexpression (D, I ). Doublemutants removingbothpink1
and omi function result in pink1mutant-like phenotypes without any enhancement (E, J ). Red arrowheads point to vacuolation
of the nebenkern, and yellow arrowsmark eachmitochondrial derivative.K–N, Mitochondria of indirect flightmuscle are labeled
by mitoGFP. Compared with control (K ), pink1 mutants display overall reduced levels of mitoGFP signal, and large clumps of
intense GFP signal (L), which can be completely rescued by pink1 overexpression (M ). Double mutants of pink1 and omi show
pink1 mutant-like phenotypes (N ). Genotypes: A, F, w. B, G, w pink15/Y. C, H, w pink15/Y; TMR-pink1/. D, I, w pink15/Y;
TMR-omi/. E, J, w pink15/Y; omiNSO/Df(3R)ED5644. K, FM6/Y; Mef2-Gal4, UAS-mitoGFP/. L, w pink15/Y; Mef2-Gal4, UAS-
mitoGFP/.M,w pink15/Y; Mef2-Gal4, UAS-mitoGFP/UAS-pink1. N,w pink15/Y; Mef2-Gal4, UAS-mitoGFP/UAS-RNAi-omi.
14506 • J. Neurosci., December 31, 2008 • 28(53):14500–14510 Yun et al. •Mutations of Omi and Its Interaction with Pink1
behave similarly to Omi WT, but differently from those with
compromised protease activity in vivo.
Discussion
The in vivo function of omi
Omi/HtrA2 has been studied extensively for its role in apoptosis
(for review, see Vande Walle et al., 2008). However, whereas
overexpression of Omi/HtrA2 induces apoptosis robustly in
mammalian cells, mice lackingOmi/HtrA2 fail to show decreased
apoptosis, but instead show nondopaminergic neuronal loss in
the striatum (Martins et al., 2004). Omi/HtrA2 function is also
implicated in regulating stress resistance (Vande Walle et al.,
2008). Thus, determining the endogenous function of Omi/
HtrA2 is crucially important to understanding its roles in both
health and disease. Using Drosophila as a model, we have dis-
sected the in vivo function of Omi. We find that omi is essential
for spermatogenesis, stress resistance, and maintaining a normal
life span. Furthermore, the protease activity of Omi is crucial for
its function.
We have identified an essential role of omi during spermato-
genesis. However, although Omi is localized to mitochondria in
both testes andmuscle, nomitochondrialmorphology defects are
observed in omi null mutants in either of these tissues. It is pos-
sible that Omi is responsible for some aspects of mitochondrial
function, such as chaperone activity ormodulation of respiratory
chain function, which do not affect mitochondrial morphology,
and thus are not detected in our assays. It is also possible that omi
is required only in certain contexts, such as during exposure to
oxidative stress, and that mitochondrial defects may be revealed
in omi mutants under these conditions. Alternatively, Omi may
function in the cytosol rather than in the mitochondria, with
mitochondria serving to regulate the release of Omi into the cy-
tosol. Future studies are required to distinguish these
possibilities.
Interaction of Omi and Pink1
The genetic interactions observed between pink1 and parkin serve
as an important reference for tests of the hypothesis that omi and
pink1 act in a common pathway. In contrast to pink1 mutants,
which show striking defects in mitochondrial integrity in muscle
and testes, and a decrease in the number of dopaminergic neu-
rons, omi mutants show normal mitochondrial morphology in
both muscle and testes, and a normal number of dopaminergic
neurons. Furthermore, in contrast to parkin overexpression, omi
overexpression does not rescue pink1mutant phenotypes. Over-
expression of pink1 also fails to rescue male sterility resulting
from omi loss of function. Lack of pink1 does not affect the levels
or the subcellular localization of Omi, and Pink1 levels and pro-
cessing are not altered in omi mutants. In addition, double mu-
tants removing both pink1 and omi show identical phenotypes to
pink1 mutants alone, suggesting that pink1 does not negatively
regulate omi and that omi does not carry out partially redundant
functions with pink1. Together, these data do not provide any in
vivo evidence supporting the hypothesis that omi functions in the
same pathway either upstream or downstream of pink1, or that it
acts in a parallel manner to regulate mitochondrial morphology.
These loss-of-function-based analyses are more relevant to PD
than are omi overexpression-based analyses, because reported
Figure 6. Omi is localized to mitochondria, and its expression is not altered in pink1 null mutants; Pink1 expression is not altered in omimutants either. A–F, Double labeling of onion-staged
spermatids in wild type (A–C) and pink1mutants (D–F ) using Pros6T-GFP (green), which labels the nucleus, and an anti-Omi antibody (red), which labels the nebenkern. In pink1 null mutants,
Omi is still localized to the nebenkerns of spermatids. G, Western blotting (WB) of endogenous Pink1–9Myc expression using a genomic rescue transgene. Loss of omi function does not alter the
cleavage pattern of Pink1.
Table 1. Summary of phenotypic effects of various Omimutants reported in this study and by others
Genotype fly (human) Molecular function from literature
Tissue-specific overexpression
Muscle
Ability to rescue omi mutant
sterility
Protease activity
from literature Testes Eye
Omi WT Sterile Small and rough Disrupted Rescue
S236C (S276C) mnd2 mice Reduced Fertile Wild type appearing Wild type appearing
S266A (S306A) Protease active site Protease dead Fertile Wild type appearing Wild type appearing Fail to rescue
G363S (G399S) PD-associated mutation Reduced Sterile Small and rough Disrupted Rescue
S364A (S400A) pinkl-dependent phosphorylation site Reduced Sterile Small and rough Disrupted
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Omi/HtrA2mutations associated with PD
are proposed to represent loss-of-function
or dominant-negative mutations (Strauss
et al., 2005).
Genetic interactions between pink1 and
omi have been observed by ourselves (see
Results) and others (Whitworth et al.,
2008) in eye-based overexpression studies:
co-overexpression of pink1 with omi re-
sults in small eye phenotypes not associ-
ated with expression of either protein
alone. Although in isolation, these results
could be explained by a model in which
omi and pink1 function in a common
pathway (Whitworth et al., 2008), this
model is difficult to reconcile with our
loss-of-function data. The cellular basis of
the pink1 overexpression-induced eye
phenotype, and its relationship to the nor-
mal endogenous roles of pink1 in regulat-
ingmitochondrial function, is unclear. Al-
though null mutants of pink1 and parkin
show highly similar, if not identical, phe-
notypes in almost all assays tested, overex-
pression of pink1 results in a rough eye
phenotype, whereas overexpression of
parkin does not (data not shown) (Poole et
al., 2008;Whitworth et al., 2008). Further-
more, a PD-causing, kinase-deficient mu-
tant form of pink1, which fails to rescue
pink1 null mutant phenotypes in multiple
tissues, still interacts with omi in the eye-
based overexpression assay, suggesting
that Pink1 kinase activity is required for its
mitochondrial functions but not for the
genetic interaction with omi in this assay.
Based on our findings, one is led to con-
clude that the functions of pink1 that me-
diate its co-overexpression interaction
with omi are distinct from the functions of
pink1 and parkin in regulating mitochon-
drial morphology. Such a mitochondrial
integrity-independent role of pinkmay be
important, but has yet to be identified in
vivo. Alternatively, it is possible that the
pink1-omi interaction observed in the eye
is not physiologically relevant. Overex-
pression studies, as well as in vitro studies,
can identify interactions that are forced to
happen, but that do not normally occur.
For example, either protein, when overex-
pressed, may act on inappropriate targets
or act in inappropriate subcellular compartments, thus generat-
ing cellular toxicity. In combination, this toxicity may be aug-
mented. This possibility is further suggested by the results of
overexpression-based observations that place Rhomboid 7 as an
upstream positive regulator of Pink1 (Whitworth et al., 2008).
This conclusion is difficult to reconcile with more physiological
loss-of-function-based observations showing that Drosophila
rhomboid 7 functions to promote mitochondrial fusion (Mc-
Quibban et al., 2006), whereas both pink1 and parkin function to
promote mitochondrial fission (Deng et al., 2008; Poole et al.,
2008; Yang et al., 2008). In any case, our loss-of-function studies
demonstrate that omi does not play an essential role in regulating
mitochondrial integrity in the pink1/parkin pathway. They leave
open the possibility that interactions between pink1 and omi are
modulatory, or important in other contexts. However, these in
vivo contexts remain to be identified.
Implications forOmi/HtrA2 as a PD gene
Omi/HtrA2was recently designated asPARK13, based on a report
identifying G399S mutations in sporadic PD patients (Strauss et
al., 2005). Mammalian cell culture studies suggest that G399S
results in a significant reduction in Omi/HtrA2 protease activity,
Figure 7. Functional analysis of Omi mutants. A, Schematic depicting positions of 4 mutations (*) with respect to domains in
Omi.B,C, Phase-contrastmicrographs. AswithoverexpressionofOmiWT (Fig. 3 E, E), expressionofG363S (C), but not S266A (B),
restores theproductionofmotile sperm in the seminal vesicle ofomimutants. Anarrow inC indicates thepresenceof sperm(phase
dark), whereas a bracket and an asterisk in B point to the absence of sperm. D, Both OmiS236C and OmiS266A are expressed at
comparable levels compared with OmiWT, as detected by an anti-Omi antibody. Western blots of head lysates from flies overex-
pressing OmiWT, OmiS236C, or OmiS266A using anti-Omi antibodies are shown. Overexpression is accomplished using the eye-
specific driver (GMR-Gal4), and flies are raised at 18°C to avoid cell death compromising recovery of proteins. A nonspecific band
(*) serves as protein loading control.E–J, ScanningEMmicrographs ofDrosophilaeyes. ComparedwithoverexpressionofOmiWT,
which results in small and rough eyes at 25°C (H ), overexpression of Omi G363S or S364A leads to similar rough eye phenotypes
(I, J ), whereas overexpression of Omi S236C or S266A results in wild-type-appearing eyes (F, G). GMR-Gal4 is used as an eye-
specific driver. Scale bars: B, C, 500m.
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providing a possible functional basis for disease association
(Strauss et al., 2005). In contrast to previous in vitro observations
(Strauss et al., 2005; Plun-Favreau et al., 2007), we find that both
G399S and S400A retain significant, if not full, Omi function in
vivo, leading to the conclusion thatmutations previously thought
to be associated with disease are functional in at least some con-
texts in vivo. Importantly, our conclusion is consistent with two
recent reports showing that Omi G399S is found at similar fre-
quencies in normal controls and PD patients (Ross et al., 2008;
Simo´n-Sa´nchez and Singleton, 2008),
We cannot exclude the possibility that humanOmi/HtrA2 has
a dopaminergic neuron-specific function that is revealed under
certain circumstances, nor can we exclude the possibility that
Drosophila omi acts differently from human Omi/HtrA2. How-
ever, the extensive homology and conservation of key domain
structures between fly and human Omi/HtrA2 suggest that it is
likely that studies in DrosophilaOmi are relevant to the function
of Omi/HtrA2 in humans. Together with the observations that
omi mutant phenotypes are distinct from those associated with
loss of pink1 and parkin function, and that pink1 and omi fail to
interact in loss-of-function-based assays, we favor a hypothesis in
which Omi/HtrA2 does not play an essential role in PD
pathogenesis.
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